Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-24

Clinical Trial Update: Disulfiram as a Modulator of Amyloid Precursor Protein-processing

View source ↗

Summary

A completed clinical trial from Johannes Gutenberg University Mainz evaluated disulfiram as a modulator of amyloid precursor protein processing in the context o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disulfiram (Disulfiram)

Snippet

Sponsor: Johannes Gutenberg University Mainz | Conditions: Alcohol Addiction | Status: COMPLETED